Fx Shoulder Solutions earned FDA 510(k) clearance for its suite of full-wedge augmented glenoid baseplates, the devicemaker said May 16.
Six new baseplate options are added to the company's portfolio with clearance, according to a news release. The augmented glenoid baseplates have 24mm diameters with different full-wedge options.
"This clearance of the full-wedge augmented baseplates further solidifies our portfolio as one of the most comprehensive and innovative shoulder arthroplasty platforms on the market," Baptiste Martin, CEO of Fx Shoulder Solutions, said in the release.